Kurt Von Emster, Director at Jasper Therapeutics, Inc. (JSPR), sold 9,075 shares at $1.49 ($14K) on 2023-04-13, disclosed to the SEC on 2023-04-14.
Open-market sale of $14k JSPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |
| CBAY | SELL | 2018-12-19 | $2.2M | — | Filing → |